129 related articles for article (PubMed ID: 38636400)
1. Tectorigenin protects against cardiac fibrosis in diabetic mice heart via activating the adiponectin receptor 1-mediated AMPK pathway.
Ma YL; Xu M; Cen XF; Qiu HL; Guo YY; Tang QZ
Biomed Pharmacother; 2024 May; 174():116589. PubMed ID: 38636400
[TBL] [Abstract][Full Text] [Related]
2. Tectorigenin attenuates diabetic nephropathy by improving vascular endothelium dysfunction through activating AdipoR1/2 pathway.
Yang S; Ma C; Wu H; Zhang H; Yuan F; Yang G; Yang Q; Jia L; Liang Z; Kang L
Pharmacol Res; 2020 Mar; 153():104678. PubMed ID: 32014572
[TBL] [Abstract][Full Text] [Related]
3. Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPKα/TGF-β/Smad signalling in type 2 diabetic rats.
Tian J; Zhang M; Suo M; Liu D; Wang X; Liu M; Pan J; Jin T; An F
J Cell Mol Med; 2021 Aug; 25(16):7642-7659. PubMed ID: 34169635
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor-21 prevents diabetic cardiomyopathy via AMPK-mediated antioxidation and lipid-lowering effects in the heart.
Yang H; Feng A; Lin S; Yu L; Lin X; Yan X; Lu X; Zhang C
Cell Death Dis; 2018 Feb; 9(2):227. PubMed ID: 29445083
[TBL] [Abstract][Full Text] [Related]
5. 4-O-methylhonokiol protects against diabetic cardiomyopathy in type 2 diabetic mice by activation of AMPK-mediated cardiac lipid metabolism improvement.
Zheng Z; Ma T; Guo H; Kim KS; Kim KT; Bi L; Zhang Z; Cai L
J Cell Mol Med; 2019 Aug; 23(8):5771-5781. PubMed ID: 31199069
[TBL] [Abstract][Full Text] [Related]
6. Cathelicidin-related antimicrobial peptide protects against cardiac fibrosis in diabetic mice heart by regulating endothelial-mesenchymal transition.
Zheng X; Peng M; Li Y; Wang X; Lu W; Wang X; Shan Y; Li R; Gao L; Qiu C
Int J Biol Sci; 2019; 15(11):2393-2407. PubMed ID: 31595157
[No Abstract] [Full Text] [Related]
7. Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function.
Sun Y; Zhou S; Guo H; Zhang J; Ma T; Zheng Y; Zhang Z; Cai L
Metabolism; 2020 Jan; 102():154002. PubMed ID: 31706979
[TBL] [Abstract][Full Text] [Related]
8. Neuraminidase 1 deficiency attenuates cardiac dysfunction, oxidative stress, fibrosis, inflammatory via AMPK-SIRT3 pathway in diabetic cardiomyopathy mice.
Guo Z; Tuo H; Tang N; Liu FY; Ma SQ; An P; Yang D; Wang MY; Fan D; Yang Z; Tang QZ
Int J Biol Sci; 2022; 18(2):826-840. PubMed ID: 35002528
[TBL] [Abstract][Full Text] [Related]
9. Cardiac fibrosis and dysfunction in experimental diabetic cardiomyopathy are ameliorated by alpha-lipoic acid.
Li CJ; Lv L; Li H; Yu DM
Cardiovasc Diabetol; 2012 Jun; 11():73. PubMed ID: 22713251
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective effects of asiaticoside against diabetic cardiomyopathy: Activation of the AMPK/Nrf2 pathway.
Xu C; Xia L; Xu D; Liu Y; Jin P; Zhai M; Mao Y; Wang Y; Wen A; Yang J; Yang L
J Cell Mol Med; 2024 Jan; 28(2):e18055. PubMed ID: 38113341
[TBL] [Abstract][Full Text] [Related]
11. Cinacalcet as a surrogate therapy for diabetic cardiomyopathy in rats through AMPK-mediated promotion of mitochondrial and autophagic function.
Elrashidy RA; Ibrahim SE
Toxicol Appl Pharmacol; 2021 Jun; 421():115533. PubMed ID: 33848515
[TBL] [Abstract][Full Text] [Related]
12. IL-37 ameliorates myocardial fibrosis by regulating mtDNA-enriched vesicle release in diabetic cardiomyopathy mice.
Huang Q; Chen T; Li J; Wang Y; Shi H; Yu Y; Ji Q; Shen X; Sun T; Shi H; Luo X; Jin B; You Y; Wu B
J Transl Med; 2024 May; 22(1):494. PubMed ID: 38790051
[TBL] [Abstract][Full Text] [Related]
13. Deletion of Smad3 protects against diabetic myocardiopathy in db/db mice.
Dong L; Li JC; Hu ZJ; Huang XR; Wang L; Wang HL; Ma RCW; Lan HY; Yang SJ
J Cell Mol Med; 2021 May; 25(10):4860-4869. PubMed ID: 33733577
[TBL] [Abstract][Full Text] [Related]
14. Si-Miao-Yong-An decoction preserves cardiac function and regulates GLC/AMPK/NF-κB and GLC/PPARα/PGC-1α pathways in diabetic mice.
Li L; Chen X; Su C; Wang Q; Li R; Jiao W; Luo H; Tian Y; Tang J; Li X; Liu B; Wang W; Zhang D; Guo S
Biomed Pharmacother; 2020 Dec; 132():110817. PubMed ID: 33068937
[TBL] [Abstract][Full Text] [Related]
15. Myeloid differential protein-2 inhibition improves diabetic cardiomyopathy via p38MAPK inhibition and AMPK pathway activation.
Qian J; Zhuang F; Chen Y; Fan X; Wang J; Wang Z; Wang Y; Xu M; Samorodov AV; Pavlov VN; Liang G
Biochim Biophys Acta Mol Basis Dis; 2022 May; 1868(5):166369. PubMed ID: 35176461
[TBL] [Abstract][Full Text] [Related]
16. Exendin-4 Protects against Hyperglycemia-Induced Cardiomyocyte Pyroptosis via the AMPK-TXNIP Pathway.
Wei H; Bu R; Yang Q; Jia J; Li T; Wang Q; Chen Y
J Diabetes Res; 2019; 2019():8905917. PubMed ID: 31886288
[TBL] [Abstract][Full Text] [Related]
17. Bicyclol Alleviates Streptozotocin-induced Diabetic Cardiomyopathy By Inhibiting Chronic Inflammation And Oxidative Stress.
Zhang L; Hu C; Jin B; Bai B; Liao J; Jin L; Wang M; Zhu W; Wu X; Zheng L; Xu X; Jiang Y; Wang Y; He Y
Cardiovasc Drugs Ther; 2024 Jun; 38(3):555-568. PubMed ID: 36662448
[TBL] [Abstract][Full Text] [Related]
18. Protection by dimethyl fumarate against diabetic cardiomyopathy in type 1 diabetic mice likely via activation of nuclear factor erythroid-2 related factor 2.
Hu X; Rajesh M; Zhang J; Zhou S; Wang S; Sun J; Tan Y; Zheng Y; Cai L
Toxicol Lett; 2018 May; 287():131-141. PubMed ID: 29408448
[TBL] [Abstract][Full Text] [Related]
19. FGF21 ameliorates diabetic cardiomyopathy by activating the AMPK-paraoxonase 1 signaling axis in mice.
Wu F; Wang B; Zhang S; Shi L; Wang Y; Xiong R; Pan X; Gong F; Li X; Lin Z
Clin Sci (Lond); 2017 Aug; 131(15):1877-1893. PubMed ID: 28559425
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA Crnde attenuates cardiac fibrosis via Smad3-Crnde negative feedback in diabetic cardiomyopathy.
Zheng D; Zhang Y; Hu Y; Guan J; Xu L; Xiao W; Zhong Q; Ren C; Lu J; Liang J; Hou J
FEBS J; 2019 May; 286(9):1645-1655. PubMed ID: 30748104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
